Literature DB >> 3531028

[Enoxacin: spectrum and activity of its antibacterial effect].

A Bauernfeind, H Flamm, H Grimm, H Hahn, F Kayser, W Opferkuch, J Potel, R Malottke, H G Sonntag, W H Traub.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3531028     DOI: 10.1007/bf01667841

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  20 in total

1.  Reduced enteral absorption of ciprofloxacin in the presence of antacids.

Authors:  G Höffken; K Borner; P D Glatzel; P Koeppe; H Lode
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

2.  In vitro activity of five quinoline derivatives against nosocomial isolates of Staphylococcus and Pseudomonas species.

Authors:  F D Daschner; H M Just
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

3.  Comparative in vitro activities of selected antimicrobial agents against Edwardsiella tarda.

Authors:  J F Reinhardt; S Fowlston; J Jones; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

4.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

5.  In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.

Authors:  R Wise; J M Andrews; G Danks
Journal:  J Antimicrob Chemother       Date:  1984-03       Impact factor: 5.790

6.  The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.

Authors:  R A Wall; D C Mabey; C S Bello; D Felmingham
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

7.  In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.

Authors:  C H Teoh-Chan; A Cowlishaw; A Eley; G Slater; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

9.  Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.

Authors:  P M Hawkey; C A Hawkey
Journal:  J Antimicrob Chemother       Date:  1984-11       Impact factor: 5.790

10.  The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  G L Ridgway; M D O'Hare; D Felmingham; R N Grüneberg
Journal:  Drugs Exp Clin Res       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.